Who are TRiCares GmbH and SAS's investors?

TRiCares GmbH and SAS's investors include European Investment Bank, 415 Capital, Andera Partners, Bayern Kapital, BioMedPartners, CapDecisif Management, Karista.

Where is TRiCares GmbH and SAS headquartered?

TRiCares GmbH and SAS is headquartered in France, FR.

TRiCares GmbH and SAS

France, FR · Founded 2018 · 67 employees on LinkedIn · 7 known investors

Find your way into TRiCares GmbH and SAS

839 people in our graph can introduce you to the TRiCares GmbH and SAS team.

Paths you didn't know you had: your email and LinkedIn already hold routes to the TRiCares GmbH and SAS team. We find them
2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

TRiCares develops the Topaz Transfemoral Tricuspid Heart Valve Replacement (TTVR) System, a minimally invasive device for treating tricuspid regurgitation. The company runs clinical studies across Europe and the US targeting structural heart institutions and cardiac patients.

Biotech Hardware Healthtech Medical Devices

Founders & leadership

Ahmed Elmouelhi President & CEOAhmed Elmouelhi is President and CEO of TRiCares, which develops minimally invasive cardiac devices for treating structural heart conditions. He has prior experience in medical device sales, marketing, product development, and clinical operations.

Esther GerteisSenior VP Medical & Regulatory Affairs

Michael LitzenburgerVP R&D

Investors · 7

European Investment Bank✓ confirmed by TRiCares GmbH and SASLuxembourg

How we know: the company's own site · Not right? Tell us

415 Capitallisted by 415 CapitalMunich · $5.4M – $16.2Mvia Frederik Groenewegen · led

How we know: 415 Capital's portfolio page · Not right? Tell us

Andera Partnerslisted by Andera PartnersParis

How we know: Andera Partners's portfolio page · a partner's Signal profile · Not right? Tell us

Bayern Kapitallisted by Bayern KapitalLandshut · $275K – $55M

How we know: Bayern Kapital's portfolio page · Not right? Tell us

BioMedPartnerslisted by BioMedPartnersBasel · $648K – $6.5M

How we know: BioMedPartners's portfolio page · the VCSheet dataset · Not right? Tell us

CapDecisif Managementlisted by CapDecisif ManagementParis

Karistalisted by KaristaParis · $324K – $5.4M

How we know: Karista's portfolio page · a partner's Signal profile · the VCSheet dataset · Not right? Tell us

Related companies · 2

Edwards LifesciencesEdwards Lifesciences develops innovative medical technologies for treating cardiovascular disease, focusing on structural heart interventions. The company serves patients and healthcare providers globally through partnerships with clinicians and healthcare stakeholders.

CardiovalveCardiovalve develops a transcatheter valve replacement system designed to fit both mitral and tricuspid anatomies via transfemoral delivery, avoiding open heart surgery. The device targets structural heart disease and is currently restricted to research use.

Companies working in the same space as TRiCares GmbH and SAS.

Frequently asked questions

What does TRiCares GmbH and SAS do?: TRiCares develops the Topaz Transfemoral Tricuspid Heart Valve Replacement (TTVR) System, a minimally invasive device for treating tricuspid regurgitation. The company runs clinical studies across Europe and the US targeting structural heart institutions and cardiac patients.
Who are TRiCares GmbH and SAS's investors?: TRiCares GmbH and SAS's investors include European Investment Bank, 415 Capital, Andera Partners, Bayern Kapital, BioMedPartners, CapDecisif Management, Karista.
Where is TRiCares GmbH and SAS headquartered?: TRiCares GmbH and SAS is headquartered in France, FR.